April 01, 2026

Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer

A novel KRAS G12D inhibitor produced disease control in almost 80% of patients with heavily pretreated advanced or metastatic KRAS G12D–mutated pancreatic cancer in an early-phase study reported at th...

The ASCO Post

March 30, 2026

New Frontiers in Neuroendocrine Tumors: Enhancing Diagnosis, Treatment, and Patient Outcomes

Explore the latest advancements in diagnosing and treating neuroendocrine tumors as discussed by Paula S. Kennedy-Newton at JADPRO Live 2025.

JADPRO

March 30, 2026

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

These results come from the pilot phase of the phase III ADARNAT randomized international clinical trial, which is investigating whether axillary radiotherapy has a lower risk of lymphedema than axill...

The ASCO Post

March 30, 2026

Therapeutic Advances in Metastatic Melanoma: TILs, ImmTACs, and Targeted Therapies

Explore the latest advances in metastatic melanoma treatment from leading experts at Mass General Hospital.

JADPRO

March 26, 2026

Clinical Trial Hopes to Boost Survival Rates with Personalized Treatment for Extensive-Stage Small Cell Lung Cancer

A clinical trial now recruiting at Roswell Park Comprehensive Cancer Center aims to redefine therapeutic stratification and improve outcomes for patients with extensive-stage small cell lung cancer (ES-SCLC).

Roswell Park Comprehensive Cancer Center

March 26, 2026

AI Use in Cancer Diagnosis, Prognosis, and Treatment: Are We There Yet?

The promise of artificial intelligence (AI) technologies to provide highly personalized oncology care for patients and improve outcomes has been decades in the making. In a 1987 editorial in The New E...

The ASCO Post

March 25, 2026

How to Increase Organ Donations in the U.S.: Education and Financial Aid Are Key

Keck Medicine of USC experts explain how transplant teams are addressing the massive shortage of organ donations in the U.S.

Keck Medicine of USC

March 24, 2026

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

A Keck Medicine of USC head and neck surgeon discusses circulating HPV DNA as a biomarker that could help make more individualized treatment decisions.

Keck Medicine of USC

March 24, 2026

Integrative Oncology Scholars Program

Applications are now being accepted for the 2026 Integrative Oncology Scholars Program and Integrative Oncology Fellows Program at the University of Michigan in Ann Arbor (https://sites.google.com/vie...

The ASCO Post

March 24, 2026

FDA Approves Teclistamab and Daratumumab For Relapsed or Refractory Multiple Myeloma

On March 5, 2026, the U.S. Food and Drug Administration (FDA) approved teclistamab (Tecvayli) in combination with daratumumab hyaluronidase-fihj for the treatment of adult patients with relapsed or re...

The ASCO Post